122 related articles for article (PubMed ID: 37994102)
1. Low molecular weight fucoidan restores diabetic endothelial glycocalyx by targeting neuraminidase2: A new therapy target in glycocalyx shedding.
Li Z; Wu N; Wang J; Yue Y; Geng L; Zhang Q
Br J Pharmacol; 2024 May; 181(9):1404-1420. PubMed ID: 37994102
[TBL] [Abstract][Full Text] [Related]
2. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight fucoidan alleviates cerebrovascular damage by promoting angiogenesis in type 2 diabetes mice.
Li Z; Wu N; Wang J; Yue Y; Geng L; Zhang Q
Int J Biol Macromol; 2022 Sep; 217():345-355. PubMed ID: 35841956
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes.
Jeong YT; Kim YD; Jung YM; Park DC; Lee DS; Ku SK; Li X; Lu Y; Chao GH; Kim KJ; Lee JY; Baek MC; Kang W; Hwang SL; Chang HW
Mol Pharmacol; 2013 Jul; 84(1):147-57. PubMed ID: 23658008
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats.
Liang Z; Zheng Y; Wang J; Zhang Q; Ren S; Liu T; Wang Z; Luo D
J Ethnopharmacol; 2016 Sep; 191():341-349. PubMed ID: 27346541
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice.
Zheng Y; Liu T; Wang Z; Xu Y; Zhang Q; Luo D
Int J Biol Macromol; 2018 Jun; 112():929-936. PubMed ID: 29447962
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum.
Marinval N; Saboural P; Haddad O; Maire M; Bassand K; Geinguenaud F; Djaker N; Ben Akrout K; Lamy de la Chapelle M; Robert R; Oudar O; Guyot E; Laguillier-Morizot C; Sutton A; Chauvierre C; Chaubet F; Charnaux N; Hlawaty H
Mar Drugs; 2016 Oct; 14(10):. PubMed ID: 27763505
[TBL] [Abstract][Full Text] [Related]
9. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Gamez M; Elhegni HE; Fawaz S; Ho KH; Campbell NW; Copland DA; Onions KL; Butler MJ; Wasson EJ; Crompton M; Ramnath RD; Qiu Y; Yamaguchi Y; Arkill KP; Bates DO; Turnbull JE; Zubkova OV; Welsh GI; Atan D; Satchell SC; Foster RR
Cardiovasc Diabetol; 2024 Feb; 23(1):50. PubMed ID: 38302978
[TBL] [Abstract][Full Text] [Related]
10. Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.
Haddad O; Guyot E; Marinval N; Chevalier F; Maillard L; Gadi L; Laguillier-Morizot C; Oudar O; Sutton A; Charnaux N; Hlawaty H
Mar Drugs; 2015 Oct; 13(11):6588-608. PubMed ID: 26516869
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight fucoidan ameliorates hindlimb ischemic injury in type 2 diabetic rats.
Wang Z; Liu T; Chen X; You H; Zhang Q; Xue J; Zheng Y; Luo D
J Ethnopharmacol; 2018 Jan; 210():434-442. PubMed ID: 28917976
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight fucoidan modified nanoliposomes for the targeted delivery of the anti-inflammation natural product berberine.
Liu L; Xing R; Xue J; Fan J; Zou J; Song X; Jia R; Zou Y; Li L; Zhou X; Lv C; Wan H; Zhao X; Yin Z
Int J Pharm; 2023 Jul; 642():123102. PubMed ID: 37277087
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight fucoidan protects endothelial function and ameliorates basal hypertension in diabetic Goto-Kakizaki rats.
Cui W; Zheng Y; Zhang Q; Wang J; Wang L; Yang W; Guo C; Gao W; Wang X; Luo D
Lab Invest; 2014 Apr; 94(4):382-93. PubMed ID: 24614196
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells.
Wang J; Zhang Q; Li S; Chen Z; Tan J; Yao J; Duan D
Int J Biol Macromol; 2020 May; 150():304-314. PubMed ID: 32057847
[TBL] [Abstract][Full Text] [Related]
15. Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells.
Xiang J; Zhang C; Di T; Chen L; Zhao W; Wei L; Zhou S; Wu X; Wang G; Zhang Y
Bioengineered; 2022 Feb; 13(2):3486-3502. PubMed ID: 35068334
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.
Chabut D; Fischer AM; Colliec-Jouault S; Laurendeau I; Matou S; Le Bonniec B; Helley D
Mol Pharmacol; 2003 Sep; 64(3):696-702. PubMed ID: 12920206
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
[TBL] [Abstract][Full Text] [Related]
18. Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease.
Cui S; Chen X; Li J; Wang W; Meng D; Zhu S; Shen S
Cell Commun Signal; 2024 Mar; 22(1):191. PubMed ID: 38528533
[TBL] [Abstract][Full Text] [Related]
19. Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy via the Hedgehog pathway.
Niu C; Chen Z; Kim KT; Sun J; Xue M; Chen G; Li S; Shen Y; Zhu Z; Wang X; Liang J; Jiang C; Cong W; Jin L; Li X
Autophagy; 2019 May; 15(5):843-870. PubMed ID: 30653446
[TBL] [Abstract][Full Text] [Related]
20. Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice.
Qiu Y; Buffonge S; Ramnath R; Jenner S; Fawaz S; Arkill KP; Neal C; Verkade P; White SJ; Hezzell M; Salmon AHJ; Suleiman MS; Welsh GI; Foster RR; Madeddu P; Satchell SC
Diabetologia; 2022 May; 65(5):879-894. PubMed ID: 35211778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
